Construction and application of microneedle-mediated photothermal therapy and immunotherapy combined anti-tumor drug delivery system

References

• Carreno BM, Magrini V, Becker-Hapak M, et al. (2015). A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science 348:1–19. doi: 10.1126/science.aaa3828.
   Web of Science ®Google Scholar
• Chen MC, Ling MH, Wang KW, et al. (2015). Near-infrared light-responsive composite microneedles for on-demand transdermal drug delivery. Biomacromolecules 16:1598–607. doi: 10.1021/acs.biomac.5b00185.
   PubMed Web of Science ®Google Scholar
• Chevolet I, Speeckaert R, Schreuer M, et al. (2015). Characterization of the in vivo immune network of IDO, tryptophan metabolism, PD-L1, and CTLA-4 in circulating immune cells in melanoma. Oncoimmunology 4:e982382. doi: 10.4161/2162402X.2014.982382.
   PubMed Web of Science ®Google Scholar
• Courtenay AJ, McCrudden MTC, McAvoy KJ, et al. (2018). Microneedle-mediated transdermal delivery of bevacizumab. Mol Pharm 15:3545–56. doi: 10.1021/acs.molpharmaceut.8b00544.
   PubMedGoogle Scholar
• Deng ZT, Jiang C, Younis MR, et al. (2021). Mild hyperthermia-enhanced chemo-photothermal synergistic therapy using doxorubicin-loaded gold nanovesicles. Chin Chem Lett 32:2411–4. doi: 10.1016/j.cclet.2021.03.080.
   Web of Science ®Google Scholar
• Dholaria B, Hammond W, Shreders A, et al. (2016). Emerging therapeutic agents for lung cancer. J Hematol Oncol 9:138. doi: 10.1186/s13045-016-0365-z.
   PubMed Web of Science ®Google Scholar
• Gao P, Wang H, Cheng YY. (2022). Strategies for efficient photothermal therapy at mild temperatures: progresses and challenges. Chin Chem Lett 33:575–86. doi: 10.1016/j.cclet.2021.08.023.
   Web of Science ®Google Scholar
• Hamdan IMN, Tekko IA, Matchett KB, et al. (2018). Intradermal delivery of a near-infrared photosensitizer using dissolving microneedle arrays. J Pharm Sci 107:2439–50. doi: 10.1016/j.xphs.2018.05.017.
   PubMed Web of Science ®Google Scholar
• Hao Y, Dong ML, Zhang TY, et al. (2017). Novel approach of using near-infrared responsive PEGylated gold nanorod coated poly(L-lactide) microneedles to enhance the antitumor efficiency of docetaxel-loaded MPEG-PDLLA micelles for treating an A431 tumor. ACS Appl Mater Interfaces 9:15317–27. doi: 10.1021/acsami.7b03604.
   PubMed Web of Science ®Google Scholar
• Jiang N, Zhou ZG, Xiong W, et al. (2021). Tumor microenvironment triggered local oxygen generation and photosensitizer release from manganese dioxide mineralized albumin-ICG nanocomplex to amplify photodynamic immunotherapy efficacy. Chin Chem Lett 32:3948–53. doi: 10.1016/j.cclet.2021.06.053.
   Web of Science ®Google Scholar
• Karande P, Mitragotri S. (2010). Transcutaneous immunization: an overview of advantages, disease targets, vaccines, and delivery technologies. Annu Rev Chem Biomol Eng 1:175–201. doi: 10.1146/annurev-chembioeng-073009-100948.
   PubMed Web of Science ®Google Scholar
• Kennedy JC, Pottier RH, Pross DC. (1990). Photodynamic therapy with endogenous protoporphyrin.9. J Photochem Photobiol B 6:143–8. doi: 10.1016/1011-1344(90)85083-9.
   PubMed Web of Science ®Google Scholar
• Lai BH, Chen DH. (2013). LaB6 nanoparticles with carbon-doped silica coating for fluorescence imaging and near-IR photothermal therapy of cancer cells. Acta Biomater 9:7556–63. doi: 10.1016/j.actbio.2013.03.034.
   PubMed Web of Science ®Google Scholar
• Liu XS, Huang N, Li H, et al. (2014). Multidentate polyethylene glycol modified gold nanorods for in vivo near-infrared photothermal cancer therapy. ACS Appl Mater Interfaces 6:5657–68. doi: 10.1021/am5001823.
   PubMed Web of Science ®Google Scholar
• Pardoll DM. (2012). The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12:252–64. doi: 10.1038/nrc3239.
   PubMed Web of Science ®Google Scholar
• Park JH, von Maltzahn G, Xu MJ, et al. (2010). Cooperative nanomaterial system to sensitize, target, and treat tumors. Proc Natl Acad Sci U S A 107:981–6. doi: 10.1073/pnas.0909565107.
   PubMed Web of Science ®Google Scholar
• Qin J, Wang X, Fan G, et al. (2022a). Recent advances in nanodrug delivery system for tumor combination treatment based on photothermal therapy. Adv Therapeut 6:200–18. doi: 10.1002/adtp.202200218.
   Google Scholar
• Qin J, Zhang J, Fan G, et al. (2022b). Cold atmospheric plasma activates selective photothermal therapy of cancer. Molecules 27:5941. doi: 10.3390/molecules27185941.
   PubMed Web of Science ®Google Scholar
• Schumacher TN, Schreiber RD. (2015). Neoantigens in cancer immunotherapy. Science 348:69–74. doi: 10.1126/science.aaa4971.
   PubMed Web of Science ®Google Scholar
• Sharma P, Allison JP. (2015). The future of immune checkpoint therapy. Science 348:56–61. doi: 10.1126/science.aaa8172.
   PubMed Web of Science ®Google Scholar
• Syn NL, Teng MWL, Mok TSK, et al. (2017). De-novo and acquired resistance to immune checkpoint targeting. Lancet Oncol 18:E731–e741. doi: 10.1016/S1470-2045(17)30607-1.
   PubMed Web of Science ®Google Scholar
• Tan SZ, Li DP, Zhu X. (2020). Cancer immunotherapy: pros, cons and beyond. Biomed Pharmacother 124:109821. doi: 10.1016/j.biopha.2020.109821.
   PubMed Web of Science ®Google Scholar
• Tham HP, Xu KM, Lim WQ, et al. (2018). Microneedle-assisted topical delivery of photodynamically active mesoporous formulation for combination therapy of deep-seated melanoma. Acs Nano 12:11936–48. doi: 10.1021/acsnano.8b03007.
   PubMed Web of Science ®Google Scholar
• Wang C, Ye YQ, Hochu GM, et al. (2016). Enhanced cancer immunotherapy by microneedle patch-assisted delivery of anti-PD1 antibody. Nano Lett 16:2334–40. doi: 10.1021/acs.nanolett.5b05030.
   PubMed Web of Science ®Google Scholar
• Yagi H, Hashizume H, Horibe T, et al. (2006). Induction of therapeutically relevant cytotoxic T lymphocytes in humans by percutaneous peptide immunization. Cancer Res 66:10136–44. doi: 10.1158/0008-5472.CAN-06-1029.
   PubMed Web of Science ®Google Scholar
• Yang YP. (2015). Cancer immunotherapy: harnessing the immune system to battle cancer. J Clin Invest 125:3335–7. doi: 10.1172/JCI83871.
   PubMed Web of Science ®Google Scholar
• Ye YQ, Wang JQ, Hu QY, et al. (2016). Synergistic Transcutaneous Immunotherapy Enhances Antitumor Immune Responses through Delivery of Checkpoint Inhibitors. Acs Nano 10:8956–63. doi: 10.1021/acsnano.6b04989.
   PubMed Web of Science ®Google Scholar
• Yu JC, Zhang YQ, Kahkoska AR, et al. (2017). Bioresponsive transcutaneous patches. Curr Opin Biotechnol 48:28–32. doi: 10.1016/j.copbio.2017.03.001.
   PubMed Web of Science ®Google Scholar
• Zhao L, Jiang M, Xu Z, et al. (2022a). Selective thermotherapy of tumor by self-regulating photothermal conversion system. J Colloid Interface Sci 605:752–65. doi: 10.1016/j.jcis.2021.07.134.
   PubMed Web of Science ®Google Scholar
• Zhao L, Wang X, Lou H, et al. (2022b). Buffet-style Cu(II) for enhance disulfiram-based cancer therapy. J Colloid Interface Sci 624:734–46. doi: 10.1016/j.jcis.2022.06.009.
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhang X, Wang X, et al. (2021). Recent advances in selective photothermal therapy of tumor. J Nanobiotechnology 19:335. doi: 10.1186/s12951-021-01080-3.
   PubMed Web of Science ®Google Scholar
• Zhao ZM, Ukidve A, Dasgupta A, et al. (2018). Transdermal immunomodulation: Principles, advances and perspectives. Adv Drug Deliv Rev 127:3–19. doi: 10.1016/j.addr.2018.03.010.
   PubMed Web of Science ®Google Scholar
• Zou WP, Wolchok JD, Chen LP. (2016). PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations. Sci Transl Med 8:238–53. doi: 10.1126/scitranslmed.aad7118.
   Web of Science ®Google Scholar